FiteBac Pharma

FiteBac develops and commercializes versatile antimicrobial technologies, centered on a platform that links quaternary ammonium antimicrobials to a polymerizable silane backbone. This approach allows for the permanent, non-leaching integration of bactericidal, fungicidal, and virucidal properties into a wide range of materials, including resins, polymers, coatings, and medical devices. The technology is distinct for its ability to be incorporated directly into material matrices during manufacturing, providing broad protection independent of surface layer wear.

These innovations are primarily applied in the medical and dental sectors, where they are utilized in products such as surgical equipment, wound dressings, dental adhesives, sealants, and acrylics to reduce healthcare-associated infections. FiteBac holds a significant portfolio of composition of matter patents and has secured FDA clearances for its medical devices and regulatory recognition for its antimicrobial molecules. By enhancing material properties and promoting healthier patient outcomes, FiteBac partners with industry leaders to provide persistent microbial protection across diverse industrial and clinical applications.